AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2011
Jan 4, 2011
35323_dirs_2011-01-04_48a9ab48-c266-4252-8ed9-4f791e74a6c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2011-01-01
Reporting Person: WHITE AUGUSTUS A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-01-03 | Common Stock | P | 10345 | $0.58 | Acquired | 179031 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-01-01 | Stock Option (Right to Buy) | $0.58 | A | 10000 | Acquired | 2021-01-01 | Common Stock (10000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8846 | Indirect |
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16